Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea
Clinical trials sponsored by Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo shows promise for rare lymphoma in Real-World study Results expected Nov 2026 (estimated)
- Engineered immune cells take on late-stage lymphoma in new trial Results expected Jan 2027 (estimated)